G.L. Pharma GmbH Labtec GmbH
PolandAll drugs from this manufacturer
-
The medicine is intended for the relief of moderate to severe pain in cancer diseases and severe pain that does not respond to other analgesics.
Dosage form: plaster, transdermal system
Active substance Dosage buprenorphine 20 mg ATC: N02AE01
-
This is an analgesic used for the treatment of moderate to severe pain in cancer diseases and severe pain that does not respond to other analgesics. It is not intended for the treatment of acute pain.
Dosage form: plaster, transdermal system
Active substance Dosage buprenorphine 30 mg ATC: N02AE01
-
This is an analgesic used to treat moderate to severe pain in cancer patients, as well as severe pain that does not respond to other painkillers. It is not suitable for the treatment of acute pain.
Dosage form: system, transdermal
Active substance Dosage buprenorphine 40 mg ATC: N02AE01